TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
EDSA

Edesa Biotech Inc

Healthcare · Biotechnology

3.60$ -2.5% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement EDSA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +103.9% +67.6% -82.0% -7.2% +93.9% -20.0% -99.8% -100.0% – – –
– +10.5% +34.2% -52.6% -16.7% -77.3% -82.6% +574.9% -0.5% +55.2% +1.4% -35.9%
– – – -312.8% – – +0.5% -138.2% – – – –
– -58.1% +68.0% +14.1% +5.8% -47.5% +203.7% +439.0% -25.7% -64.0% -39.9% +27.3%
– +12.4% +3.0% -11.4% -6.4% -25.8% +65.4% +69.5% -12.2% -12.1% -6.7% +2.7%
– -20.1% +18.7% -2.6% -1.5% -35.2% +113.6% +252.8% -22.4% -49.8% -23.9% +11.1%
– – – – – – – – – – – –
– – – – – – +67.1% +23.1% +603.5% – – –
– – – – – – – – – – – –
– +35.3% -80.4% -88.9% +0.0% -7,025.5% – +0.0% +0.0% +0.0% +0.0% +0.0%
– – – – – – – – – – – –
– – – – – – – – – – – –

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?